GlassScriptPhysician profile
Victor J Weinstein
NPI 1750348850
$1,149.98
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $193 · 2021: $150 · 2022: $190 · 2023: $18.93 · 2024: $23.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $206.45 | 2019-2020 | |
| Coloplast Corp | $168.06 | 2019 | |
| Abbvie INC. | $124.77 | 2019-2022 | |
| Axonics, INC. | $102.67 | 2022 | |
| Therapeuticsmd, INC. | $86.37 | 2019-2021 | |
| Allergan, INC. | $52.86 | 2019 | |
| Duchesnay USA Incorporated | $48.18 | 2019 | |
| Mayne Pharma Commercial LLC | $44.08 | 2022-2024 | |
| Organon LLC | $43.14 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $39.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.24 | 2019-2020 | |
| Exeltis, USA INC. | $31.74 | 2021-2023 | Slynd |
| Novo Nordisk INC | $28.75 | 2019-2020 | |
| Myovant Sciences INC. | $27.08 | 2022 | |
| Daiichi Sankyo INC. | $22.90 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.32 | 2019 | |
| Pfizer INC. | $15.09 | 2021 | |
| Evofem Biosciences, INC. | $14.50 | 2021 | |
| Avion Pharmaceuticals | $14.12 | 2021 | |
| Zyla Life Sciences, INC. | $12.54 | 2019 | |
| Merck Sharp & Dohme LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.